These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
133 related articles for article (PubMed ID: 19390185)
1. Influence of cyclooxygenase-1 genotype on ex vivo aspirin response in patients at risk for stroke. Momary KM; Shapiro NL; Brace LD; Shord SS; Grossi E; Viana MA; Helgason CM; Nutescu EA; Cavallari LH Cerebrovasc Dis; 2009; 27(6):585-93. PubMed ID: 19390185 [TBL] [Abstract][Full Text] [Related]
2. Heritability of platelet responsiveness to aspirin in activation pathways directly and indirectly related to cyclooxygenase-1. Faraday N; Yanek LR; Mathias R; Herrera-Galeano JE; Vaidya D; Moy TF; Fallin MD; Wilson AF; Bray PF; Becker LC; Becker DM Circulation; 2007 May; 115(19):2490-6. PubMed ID: 17470694 [TBL] [Abstract][Full Text] [Related]
3. Effect of PEAR1, PTGS1 gene polymorphisms on the recurrence of aspirin-treated patients with ischemic stroke in the Han population of China: A 4-year follow-up study. Zhang L; Meng Z; Wang H; Miao Y Medicine (Baltimore); 2024 May; 103(19):e38031. PubMed ID: 38728491 [TBL] [Abstract][Full Text] [Related]
4. Cyclooxygenase polymorphisms and risk of cardiovascular events: the Atherosclerosis Risk in Communities (ARIC) study. Lee CR; North KE; Bray MS; Couper DJ; Heiss G; Zeldin DC Clin Pharmacol Ther; 2008 Jan; 83(1):52-60. PubMed ID: 17495879 [TBL] [Abstract][Full Text] [Related]
5. The role of platelet glycoprotein IIIa polymorphism in the high prevalence of in vitro aspirin resistance in patients with intracoronary stent restenosis. Pamukcu B; Oflaz H; Nisanci Y Am Heart J; 2005 Apr; 149(4):675-80. PubMed ID: 15990752 [TBL] [Abstract][Full Text] [Related]
7. Evaluation of dose-related effects of aspirin on platelet function: results from the Aspirin-Induced Platelet Effect (ASPECT) study. Gurbel PA; Bliden KP; DiChiara J; Newcomer J; Weng W; Neerchal NK; Gesheff T; Chaganti SK; Etherington A; Tantry US Circulation; 2007 Jun; 115(25):3156-64. PubMed ID: 17562955 [TBL] [Abstract][Full Text] [Related]
8. Association between PTGS1 polymorphisms and functional outcomes in Chinese patients with stroke during aspirin therapy: Interaction with smoking. Cai H; Cai B; Sun L; Zhang H; Zhou S; Cao L; Guo H; Sun W; Yan B; Davis SM; Zhang Z; Liu X J Neurol Sci; 2017 May; 376():211-215. PubMed ID: 28431615 [TBL] [Abstract][Full Text] [Related]
9. Genetic Variant in Human PAR (Protease-Activated Receptor) 4 Enhances Thrombus Formation Resulting in Resistance to Antiplatelet Therapeutics. Tourdot BE; Stoveken H; Trumbo D; Yeung J; Kanthi Y; Edelstein LC; Bray PF; Tall GG; Holinstat M Arterioscler Thromb Vasc Biol; 2018 Jul; 38(7):1632-1643. PubMed ID: 29748334 [TBL] [Abstract][Full Text] [Related]
10. Increased platelet sensitivity among individuals with aspirin resistance - platelet aggregation to submaximal concentration of arachidonic acid predicts response to antiplatelet therapy. Guthikonda S; Mangalpally K; Vaduganathan M; Patel R; Delao T; Bergeron AL; Dong JF; Lev EI; Kleiman NS Thromb Haemost; 2008 Jul; 100(1):83-9. PubMed ID: 18612542 [TBL] [Abstract][Full Text] [Related]
11. Drug resistance and pseudoresistance: an unintended consequence of enteric coating aspirin. Grosser T; Fries S; Lawson JA; Kapoor SC; Grant GR; FitzGerald GA Circulation; 2013 Jan; 127(3):377-85. PubMed ID: 23212718 [TBL] [Abstract][Full Text] [Related]
13. Heritability, platelet function, and aspirin: a link established but cause unknown. Freedman JE Circulation; 2007 May; 115(19):2468-70. PubMed ID: 17502587 [No Abstract] [Full Text] [Related]
14. Residual arachidonic acid-induced platelet activation via an adenosine diphosphate-dependent but cyclooxygenase-1- and cyclooxygenase-2-independent pathway: a 700-patient study of aspirin resistance. Frelinger AL; Furman MI; Linden MD; Li Y; Fox ML; Barnard MR; Michelson AD Circulation; 2006 Jun; 113(25):2888-96. PubMed ID: 16785341 [TBL] [Abstract][Full Text] [Related]
15. Assessment of the antiplatelet effects of low to medium dose aspirin in the early and late phases after ischaemic stroke and TIA. McCabe DJ; Harrison P; Mackie IJ; Sidhu PS; Lawrie AS; Purdy G; Machin SJ; Brown MM Platelets; 2005 Aug; 16(5):269-80. PubMed ID: 16011977 [TBL] [Abstract][Full Text] [Related]